We maintain our BUY rating as we remain optimistic on SAB’s ability to generate strong earnings growth from its ongoing business restructuring. We believe SAB’s 22% share price correction over the last three months has priced in the potential negative impact on industry sales volume from Decree 100/2019 on drunk driving and the coronavirus (CoV) breakout.